Haluska Frank
SVP, Clinical R&D, CMO at ARIAD PHARMACEUTICALS INC
- Sold, on record
- $1.4M
- Dollars the filings state
- Form 4 sales
- 20
- Latest Mar 21, 2016
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ARIAD PHARMACEUTICALS INCSVP, Clinical R&D, CMO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedApr 2 2014
Sold 3,400 shares at $8.21 ($28k)
Haluska Frank, SVP, Clinical R&D, CMO
Sold 3.2% of holdings ($884k position)104,296 shares left0.9x usual sizeFiling
- 2 Form 4 sale ARIAD PHARMACEUTICALS INCUnusualFeb 2 +306 days
Sold 16,134 shares at $6.33 ($102k)
Haluska Frank, SVP, Clinical R&D, CMO
Sold 12.9% of holdings ($789k position)108,499 shares left4.7x usual sizeFiling
- 3 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedMar 23 +49 days
Sold 6,875 shares at $8.71 ($60k)
Haluska Frank, SVP, Clinical R&D, CMO
Sold 5.7% of holdings ($1.1M position)114,124 shares left1.6x usual sizeFiling
- 4 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedJul 16 +115 days
Sold 4,400 shares at $8.54 ($38k)
Haluska Frank, SVP, Clinical R&D, CMO
Sold 3.6% of holdings ($1M position)117,724 shares left0.8x usual sizeFiling
- 5 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedSep 28 +74 days
Sold 5,500 shares at $6.46 ($36k)
Haluska Frank, SVP, Clinical R&D, CMO
Sold 4.3% of holdings ($825k position)122,224 shares left1.2x usual sizeFiling
- 6 Form 4 sale ARIAD PHARMACEUTICALS INCUnusualFeb 1 +126 days
Sold 16,133 shares at $4.81 ($78k)
Haluska Frank, SVP, Clinical R&D, CMO
Sold 10.6% of holdings ($729k position)135,424 shares left3.3x usual sizeFiling
- 7 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedMar 3 +31 days
Sold 10,588 shares at $6.11 ($65k)
Haluska Frank, SVP, Clinical R&D, CMO
Sold 6.8% of holdings ($945k position)144,086 shares left1.9x usual sizeFiling
- 8 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedMar 21 +18 days
Sold 3,575 shares at $6.47 ($23k)
Haluska Frank, SVP, Clinical R&D, CMO
Sold 2.4% of holdings ($974k position)147,011 shares left0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (20)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2016 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 3,575 | $23k | 2.4% | Plan not stated | SEC |
| Mar 3, 2016 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 10,588 | $65k | 6.8% | Plan not stated | SEC |
| Feb 1, 2016 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 16,133 | $78k | 10.6% | Unusual | SEC |
| Sep 28, 2015 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 5,500 | $36k | 4.3% | Plan not stated | SEC |
| Jul 16, 2015 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 4,400 | $38k | 3.6% | Plan not stated | SEC |
| Mar 23, 2015 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 6,875 | $60k | 5.7% | Plan not stated | SEC |
| Feb 2, 2015 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 16,134 | $102k | 12.9% | Unusual | SEC |
| Apr 2, 2014 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 3,400 | $28k | 3.2% | Plan not stated | SEC |
| Mar 21, 2014 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 2,400 | $19k | 2.4% | Plan not stated | SEC |
| Dec 19, 2013 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 5,100 | $26k | 5.3% | Plan not stated | SEC |
| Jul 18, 2013 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 6,400 | $127k | 7.1% | Plan not stated | SEC |
| Apr 2, 2013 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 3,400 | $61k | 4.4% | Plan not stated | SEC |
| Mar 25, 2013 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 5,333 | $101k | 7.2% | Plan not stated | SEC |
| Mar 22, 2013 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 2,400 | $47k | 3.8% | Plan not stated | SEC |
| May 2, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 3,000 | $51k | 5.7% | Plan not stated | SEC |
| Apr 3, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 4,250 | $69k | 7.9% | Plan not stated | SEC |
| Mar 26, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 3,000 | $48k | 6.2% | Plan not stated | SEC |
| Mar 23, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 6,667 | $103k | 12.8% | Plan not stated | SEC |
| Mar 20, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 15,000 | $225k | 27.8% | Unusual | SEC |
| Feb 21, 2012 | ARIAD PHARMACEUTICALS INC | SVP, Clinical R&D, CMO | Form 4 sale | 4,500 | $65k | 15.9% | Plan not stated | SEC |